[On the effect of pyrimidines and their precursors on the diabetogenic activity of alloxan].
D000496:Alloxan / Q000494:pharmacology*; D000818:Animals; D001224:Aspartic Acid / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D003596:Cytosine / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental; D005260:Female; D008112:Liver Glycogen / Q000032:analysis; D009696:Nucleic Acids / Q000096:biosynthesis; D009963:Orotic Acid / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology*; D051381:Rats; D013941:Thymine / Q000494:pharmacology; D014498:Uracil / Q000494:pharmacology; D014527:Uric Acid / Q000097:blood
D001463:Barbiturates; D001786:Blood Glucose; D008112:Liver Glycogen; D009696:Nucleic Acids; D011743:Pyrimidines; D014527:Uric Acid; D001224:Aspartic Acid; D014498:Uracil; D009963:Orotic Acid; D000496:Alloxan; D003596:Cytosine; D013941:Thymine
Uber den Einfluss von Pyrimidinen und ihren Vorstufen auf die diabetogene Wirkung von Alloxan.